0% Complete
Question 1 of 13
This model can be used in adults with IgA nephropathy to predict the benefit an individual might receive from treatment with corticosteroids expressed as the absolute reduction in risk of a 40% decline in eGFR, ESKD or death due to kidney disease.
Question 1 of 13
This is used to determine the time from biopsy to the treatment decision date as a predictor in the model.